High materiality7/10
Ionis Pharmaceuticals price target lowered to $84 from $87 at Raymond James
Why it may matterVerify against the original reporting
Upside remains as target is well above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James lowers Ionis target to $84 from $87; current price $56.42.
- Raymond James lowers Ionis target to $84 from $87; price $56.42
Key facts
- 01
Target: $84
- 02
Posted price: $56.42
- 03
Analyst firm: Raymond James
- 04
Analyst: Tiago Fauth
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.